Article Listing - Merck Serono's oral MS drug cladribine gets second approval, in Australia

BTG'S rhGH APPROVED IN FRANCE

27 April 1992

US biotechnology company Bio-Technology General Corp has received approval to market Eskatrope, its recombinant version of human growth hormone which...

SOTALOL BEST, SAYS ARRHYTHMIA STUDY

27 April 1992

Results of an arm of the ESVEM (electrophysiologic study versus electrocardiographic monitoring) study have indicated that the beta blocker and...

BAXTER PRESIDENT TO FORM NEW VENTURE

27 April 1992

Baxter International's president Wilbur Gantz will shortly leave the company to become founder, president and chief executive of a new...

EUROCETUS TO MARKET PROLEUKIN

27 April 1992

US pharmaceutical company Chiron's Dutch subsidiary, EuroCetus BV, has received approval from the Austrian Board of Health to market Proleukin...

MYLAN TO MARKET GEMFIBROZIL IN USA

27 April 1992

Mylan Laboratories has received US Food and Drug Administration approval to market a generic formulation of the hypolipemic gemfibrozil in...

JAPAN'S 1st TYMPANIC THERMOMETER

27 April 1992

Japan's Tanabe Seiyaku Company and Omron Corp report that they have jointly developed a tympanic thermometer, the Quick Thermo MC-500,...

STOCK MARKET COMMENTARY: EUROPE

27 April 1992

EUROPE: saw the majority of markets close slightly firmer on Thursday, April 16 for the four-day Easter holiday. PARIS sentiment...

GERMAN HEALTH COST DEBATE HOTS UP

27 April 1992

The debate as to how to control ever-rising German health care spending has intensified with controversial new proposals from the...

MEXICO COMMENTS ON LOW DRUG PRICE SCHEME

27 April 1992

In commenting on the possible advantages for the Mexican pharmaceutical industry under the North American Free Trade Agreement, the Mexican...

ROMANIA INVESTMENT

27 April 1992

A recent communique issued by the Romanian government said that foreign investment in the country's pharmaceutical industry will be given...

Showing 94141-94150 of 95360 articles